Sara Hurvitz named SVP of the Clinical Research Division at Fred Hutch, head of the Division of Hematology and Oncology at UW

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

Drugs & Targets

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

ConcertAI announced a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.

December 06, 2024

Vol.50 No.45

In Brief

Nicole Fleming joins Fred Hutch as deputy CMO

Nicole D. Fleming has joined Fred Hutch Cancer Center as the new deputy chief medical officer. Fleming brings expertise as a doctor, surgeon, researcher, administrator, mentor, and mother of three school-age children that fits well with the mission of a recently merged organization coping with growing pains.

November 15, 2024

Vol.50 No.43

In Brief

Fred Hutch receives $2M gift to endow the Bob and Pat Herbold Computational Biology Endowed Chair

Fred Hutchinson Cancer Center received a $2 million gift from philanthropists Bob and Pat Herbold to create the Bob and Pat Herbold Computational Biology Endowed Chair.

November 15, 2024

Vol.50 No.43

In Brief

Fred Hutch, UW, and Seattle Children’s consortium researchers receive $1.7M from Breast Cancer Research Foundation

Six Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium scientists received $1.7M in grants from Breast Cancer Research Foundation to launch or continue studies aimed at improving outcomes in breast cancer.

November 15, 2024

Vol.50 No.43

Clinical Roundup

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

In preclinical work recently published in Nature Communications, Fred Hutchinson Cancer Center scientists used a genetic “chain reaction” to transform herpes simplex virus DNA during an HSV infection.

November 15, 2024

Vol.50 No.43

Sara Hurvitz named SVP of the Clinical Research Division at Fred Hutch, head of the Division of Hematology and Oncology at UW

YOU MAY BE INTERESTED IN

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Nicole Fleming joins Fred Hutch as deputy CMO

Fred Hutch receives $2M gift to endow the Bob and Pat Herbold Computational Biology Endowed Chair

Fred Hutch, UW, and Seattle Children’s consortium researchers receive $1.7M from Breast Cancer Research Foundation

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

Renew today!

Subscriber content

Never miss an issue!

Login